<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00662727</url>
  </required_header>
  <id_info>
    <org_study_id>ESMR-RCT-IL</org_study_id>
    <nct_id>NCT00662727</nct_id>
  </id_info>
  <brief_title>Extracorporeal Shockwave Therapy for the Treatment of Refractory Angina Pectoris</brief_title>
  <official_title>Randomized, Placebo Controlled, Double Blind Clinical Trial Evaluating the Treatment of Patients With Refractory Angina Pectoris With Low Intensity Extracorporeal Shockwave Therapy Device</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medispec</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hadassah Medical Organization</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Medispec</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Low intensity shockwaves have been proven in animal studies to induce local growth of new
      blood vessels from existing ones.

      The hypothesis of this study is that shockwave therapy could improve the symptoms of patients
      with refractory angina not amenable to revascularization with angioplasty or bypass surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Low intensity shockwaves (1/10 the ones used in Lithotripsy) are delivered to myocardial
      ischemic tissue. Shockwaves are created by a special generator and are focused using a
      shockwave applicator device. The treatment is guided by standard echocardiography equipment.
      The shockwaves are delivered in synchronization with Patient R-wave to avoid arrhythmias. The
      treatment is painless.

      At first, the patient undergoes stress- SPECT testing to identify the ischemic areas.
      Following that, the same area is localized by the ultra-sound device and the shockwaves are
      focused to the ischemic area. Several treatments are required for optimal results.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2007</start_date>
  <completion_date type="Actual">November 2012</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total Exercise Time</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in SPECT</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in AP-CCS</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">28</enrollment>
  <condition>Refractory Angina Pectoris</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A - Treatment group. Patients in this group receive actual shockwave therapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo group. This group of patients undergo the same procedure as the treatment group, however shockwaves are not delivered to the heart.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cardiac Extracorporeal Shockwave Therapy generator (Cardiospec)</intervention_name>
    <description>Energy Density - 0.09 mJ/mm2</description>
    <arm_group_label>A</arm_group_label>
    <other_name>Cardiospec</other_name>
    <other_name>ESMR therapy</other_name>
    <other_name>Extracorporeal Shockwave Myocardial Revascularization</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo</description>
    <arm_group_label>B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosed with chronic stable angina pectoris.

          -  Documented myocardial segments with reversible ischemia

          -  AP CCS class of III-IV.

          -  Stable dosage of medication used to treat angina for at least 6 weeks prior to
             enrollment.

          -  Exercise tolerance time &lt; 10 min (modified Bruce)

          -  Two ETT tests results (within two weeks) averaging no more than 25% of their mean

          -  Documented epicardial coronary artery disease not amenable to angioplasty or CABG.

          -  Signed an IRB approved informed consent form.

          -  Life expectancy of &gt;12 months.

        Exclusion Criteria:

          -  Intraventricular thrombus

          -  Malignancy in the area of treatment

          -  Severe COPD

          -  No smoking during the study procedure

          -  MI less &lt;3 months prior to treatment

          -  Severe Valvular disease

          -  Child bearing potential
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Leibowitz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hadassah Medical Organization</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hadassah-Hebrew University Medical Center</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>February 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 14, 2008</study_first_submitted>
  <study_first_submitted_qc>April 18, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 21, 2008</study_first_posted>
  <last_update_submitted>February 17, 2013</last_update_submitted>
  <last_update_submitted_qc>February 17, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 20, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Extracorporeal Shockwave Therapy</keyword>
  <keyword>Myocardial Ischemia</keyword>
  <keyword>Refractory Angina</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Angina Pectoris</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

